Mark Jacobson
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $575,000 | $4,208,131 |
| 2024 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $552,000 | $4,245,813 |
| 2023 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $530,000 | $4,036,250 |
| 2022 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $483,000 | $3,785,242 |
| 2021 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $409,000 | $4,794,824 |
| 2020 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $375,000 | $2,365,005 |
| 2019 | Axsome Therapeutics, Inc. (AXSM) | M.A. Chief Operating Officer | $310,000 | $1,955,681 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.